We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$600M
AUM Growth
+$420M
Cap. Flow
+$429M
Cap. Flow %
71.56%
Top 10 Hldgs %
7.78%
Holding
1,485
New
912
Increased
233
Reduced
74
Closed
263

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.8%
2 Industrials 15.11%
3 Healthcare 13.87%
4 Technology 12.38%
5 Financials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBIO icon
1076
Harvard Bioscience
HBIO
$29.2M
$143K 0.02%
+4,758
New +$160K
ARD
1077
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$143K 0.02%
+10,200
New +$147K
MAC icon
1078
Macerich
MAC
$6.92B
$141K 0.02%
+20,753
New +$163K
SMBK icon
1079
SmartFinancial
SMBK
$888M
$141K 0.02%
+10,372
New +$147K
ENZ
1080
DELISTED
Enzo Biochem, Inc.
ENZ
$141K 0.02%
66,672
+52,761
+379% +$125K
DCOM
1081
DELISTED
Dime Community Bancshares
DCOM
$141K 0.02%
+12,475
New +$155K
TXMD icon
1082
TherapeuticsMD
TXMD
$24M
$138K 0.02%
1,746
-452
-21% -$36K
MAGN
1083
Magnera Corp
MAGN
$460M
$138K 0.02%
+772
New +$154K
FENC icon
1084
Fennec Pharmaceuticals
FENC
$402M
$136K 0.02%
+22,385
New +$158K
GILT icon
1085
Gilat Satellite Networks
GILT
$848M
$136K 0.02%
+25,035
New +$138K
UEC icon
1086
Uranium Energy
UEC
$5.57B
$136K 0.02%
+136,376
New +$140K
ATNM icon
1087
Actinium Pharmaceuticals
ATNM
$25M
$134K 0.02%
+13,823
New +$152K
AVXL icon
1088
Anavex Life Sciences
AVXL
$310M
$134K 0.02%
+29,484
New +$127K
QVCGA
1089
DELISTED
QVC Group Inc Series A
QVCGA
$133K 0.02%
+371
New +$176K
MRKR icon
1090
Marker Therapeutics
MRKR
$18.7M
$132K 0.02%
8,791
+6,946
+376% +$127K
RFP
1091
DELISTED
Resolute Forest Products Inc.
RFP
$132K 0.02%
29,409
-26,883
-48% -$101K
CDXS icon
1092
Codexis
CDXS
$158M
$131K 0.02%
+11,161
New +$139K
KA
1093
DELISTED
Kineta, Inc. Common Stock
KA
$131K 0.02%
852
+494
+138% +$92.8K
TGLS icon
1094
Tecnoglass Holdings Inc.
TGLS
$1.96B
$129K 0.02%
+24,377
New +$130K
USAK
1095
DELISTED
USA Truck Inc
USAK
$129K 0.02%
+13,631
New +$139K
DHT icon
1096
DHT Holdings
DHT
$3.02B
$127K 0.02%
24,697
-35,666
-59% -$197K
KIM icon
1097
Kimco Realty
KIM
$16.4B
$127K 0.02%
+11,298
New +$133K
PAYS icon
1098
Paysign
PAYS
$705M
$127K 0.02%
+22,409
New +$175K
TCPC icon
1099
BlackRock TCP Capital
TCPC
$345M
$127K 0.02%
+12,900
New +$125K
MTEM
1100
DELISTED
Molecular Templates, Inc.
MTEM
$127K 0.02%
+773
New +$137K

Similar funds

GSA Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, GSA Capital Partners held 1,485 positions worth $600M, up 234% from $179M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

GSA Capital Partners deployed $429M of net new capital in Q3 2020, opening 912 new positions and adding to 233 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $5.11M trimmed.

  • GSA Capital Partners's largest Q3 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.
  • GSA Capital Partners added most to Michaels Stores, Inc in Q3 2020, an estimated $2.48M increase.
  • GSA Capital Partners's biggest Q3 2020 reduction was Nebius Group N.V., cutting an estimated $5.11M.
  • GSA Capital Partners fully exited T-Mobile US in Q3 2020, selling an estimated $1.77M.
  • GSA Capital Partners's ten largest holdings make up 7.8% of its $600M portfolio in Q3 2020.
  • GSA Capital Partners opened 912 new positions and closed 263 in Q3 2020.
  • GSA Capital Partners's portfolio value rose 234% quarter-over-quarter to $600M.

Based on GSA Capital Partners's 13F filing for Q3 2020, filed 6 Nov 2020.